Montrose Environmental Group Announces Third Quarter 2021 Results
Montrose Environmental Group, Inc. (MEG) reported strong third quarter results for 2021, with total revenue of $132.6 million, a 56.5% increase year-over-year. Net income reached $2.2 million, compared to a net loss of $30.7 million in the prior year. Adjusted EBITDA rose 28.6% to $21.5 million with a margin of 16.2%. The company completed two strategic acquisitions and successfully reduced its leverage to 0.8x after a public offering that raised approximately $169.8 million. Montrose has raised its full-year Adjusted EBITDA guidance to $75-$80 million.
- Q3 2021 revenue increased 56.5% to $132.6 million.
- Net income improved to $2.2 million from a loss of $30.7 million year-over-year.
- Adjusted EBITDA grew 28.6% to $21.5 million with a 16.2% margin.
- Completed two acquisitions, boosting strategic growth.
- Leverage reduced to 0.8x after a successful public offering.
- Adjusted EBITDA margin declined 350 basis points from 19.7% to 16.2%.
- Continued Execution Drove Solid Third Quarter Results -
- Completed Strategically and Financially Accretive Acquisitions -
- Strengthened Balance Sheet With Successful October Equity Offering Reducing Leverage to 0.8x* -
- Increased Guidance for Full Year 2021 -
Third Quarter 2021 Highlights
-
Total revenue of
increased$132.6 million 56.5% compared to the prior year quarter. -
Net income of
compared to a net loss of$2.2 million in the prior year quarter, largely due to higher revenues and fair value adjustment charges in the prior year.$30.7 million -
Adjusted EBITDA1 of
increased$21.5 million 28.6% compared to the prior year quarter. Adjusted EBITDA margin1 of16.2% . - Completed two strategically and financially accretive transactions in the third quarter.
First Nine Months 2021 Highlights
-
Total revenue of
increased$402.6 million 83.4% compared to the prior year period. -
Net loss of
compared to a net loss of$23.9 million in the prior year period, primarily due to higher revenues and lower fair value adjustment charges in the current year versus the prior year.$58.8 million -
Adjusted EBITDA1 of
grew$59.2 million 63.9% compared to the prior year period. Adjusted EBITDA margin1 of14.7% .
* |
Leverage is calculated under Montrose’s credit agreement, pro forma for the follow-on offering completed in |
|
(1) | Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP measures. See the appendix to this release for a discussion of these measures, including how they are calculated and the reasons why we believe they provide useful information to investors, and a reconciliation of Adjusted EBITDA to net income (loss), the most directly comparable GAAP measure. |
|
“We continue to experience strong performance across our business which was evident during the third quarter as it has been in prior quarters,” stated
Third Quarter 2021 Results
Total revenue in the third quarter of 2021 increased
Net income was
Adjusted EBITDA1 increased to
First Nine Months 2021 Results
Total revenue in the first nine months of 2021 increased
Net loss was
Adjusted EBITDA1 increased
Operating Cash Flow Liquidity and Capital Resources
Cash flow from operating activities for the nine months ended
At
In
Recent Acquisitions
In
In
Full Year 2021 Outlook
Because demand for environmental services does not follow fiscal quarter patterns, the Company’s business is best assessed on yearly results. Given the outperformance of CTEH, continued organic growth across its segments, and the contribution of completed acquisitions, the Company now expects full year 2021 Adjusted EBITDA1 to be in the range of
Given the emergency response dynamic and impact of CTEH’s performance in 2021, the Company expects to initiate 2022 guidance based off its base business and a more normalized CTEH, taking into consideration acquisitions completed in 2021 and continued organic growth acceleration across other business lines.
The Company’s outlook continues to be based on a combination of high single digit organic growth plus the contribution of completed acquisitions. The outlook does not include any benefit from future acquisitions that have not yet been completed.
Webcast and Conference Call
The Company’s senior management will host a webcast and conference call on
About Montrose
Montrose is a leading environmental services company focused on supporting commercial and government organizations as they deal with the challenges of today, and prepare for what’s coming tomorrow. With more than 2000 employees across over 70 locations around the world, Montrose combines deep local knowledge with an integrated approach to design, engineering, and operations, enabling the Company to respond effectively and efficiently to the unique requirements of each project. From comprehensive air measurement and laboratory services to regulatory compliance, emergency response, permitting, engineering, and remediation, Montrose delivers innovative and practical solutions that keep its clients on top of their immediate needs – and well ahead of the strategic curve. For more information, visit www.montrose-env.com.
Forward‐Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as “intend,” “expect”, and “may”, and other similar expressions that predict or indicate future events or that are not statements of historical matters. Forward-looking statements are based on current information available at the time the statements are made and on management’s reasonable belief or expectations with respect to future events, and are subject to risks and uncertainties, many of which are beyond the Company’s control, that could cause actual performance or results to differ materially from the belief or expectations expressed in or suggested by the forward-looking statements. Further, many of these factors are, and may continue to be, amplified by the COVID-19 pandemic. Additional factors or events that could cause actual results to differ may also emerge from time to time, and it is not possible for the Company to predict all of them. Forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update any forward-looking statement to reflect future events, developments or otherwise, except as may be required by applicable law. Investors are referred to the Company’s filings with the
|
|||||||||||||||||||||||
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
||||||||||||||||
|
|
|
|
|
|
|
|
||||||||||||||||
|
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
|
||||||||||
REVENUES |
|
$ |
132,578 |
|
|
$ |
84,705 |
|
|
$ |
402,619 |
|
|
$ |
219,502 |
|
|||||||
COST OF REVENUES (exclusive of depreciation and amortization shown below) |
|
|
85,242 |
|
|
|
51,828 |
|
|
|
272,662 |
|
|
|
142,115 |
|
|||||||
SELLING, GENERAL AND ADMINISTRATIVE EXPENSE |
|
|
30,499 |
|
|
|
24,442 |
|
|
|
82,865 |
|
|
|
64,810 |
|
|||||||
FAIR VALUE CHANGES IN BUSINESS ACQUISITIONS CONTINGENT CONSIDERATION |
|
|
— |
|
|
|
13,404 |
|
|
|
24,035 |
|
|
|
17,387 |
|
|||||||
DEPRECIATION AND AMORTIZATION |
|
|
11,471 |
|
|
|
9,740 |
|
|
|
33,145 |
|
|
|
27,084 |
|
|||||||
INCOME (LOSS) FROM OPERATIONS |
|
|
5,366 |
|
|
|
(14,709 |
) |
|
|
(10,088 |
) |
|
|
(31,894 |
) |
|||||||
OTHER EXPENSE |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Other expense |
|
|
(516 |
) |
|
|
(9,637 |
) |
|
|
(1,909 |
) |
|
|
(17,534 |
) |
|||||||
Interest expense—net |
|
|
(1,722 |
) |
|
|
(3,043 |
) |
|
|
(11,208 |
) |
|
|
(10,896 |
) |
|||||||
Total other expenses—net |
|
|
(2,238 |
) |
|
|
(12,680 |
) |
|
|
(13,117 |
) |
|
|
(28,430 |
) |
|||||||
INCOME (LOSS) BEFORE EXPENSE (BENEFIT) FROM INCOME TAXES |
|
|
3,128 |
|
|
|
(27,389 |
) |
|
|
(23,205 |
) |
|
|
(60,324 |
) |
|||||||
INCOME TAX EXPENSE (BENEFIT) |
|
|
902 |
|
|
|
3,348 |
|
|
|
648 |
|
|
|
(1,563 |
) |
|||||||
NET INCOME (LOSS) |
|
$ |
2,226 |
|
|
$ |
(30,737 |
) |
|
$ |
(23,853 |
) |
|
$ |
(58,761 |
) |
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
EQUITY ADJUSTMENT FROM FOREIGN CURRENCY TRANSLATION |
|
|
(74 |
) |
|
|
80 |
|
|
|
(17 |
) |
|
|
27 |
|
|||||||
COMPREHENSIVE INCOME (LOSS) |
|
|
2,152 |
|
|
|
(30,657 |
) |
|
|
(23,870 |
) |
|
|
(58,734 |
) |
|||||||
ACCRETION OF REDEEMABLE SERIES A-1 PREFERRED STOCK |
|
|
— |
|
|
|
(6,542 |
) |
|
|
— |
|
|
|
(17,601 |
) |
|||||||
REDEEMABLE SERIES A-1 PREFERRED STOCK DEEMED DIVIDEND |
|
|
— |
|
|
|
(24,341 |
) |
|
|
— |
|
|
|
(24,341 |
) |
|||||||
CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK DIVIDEND |
|
|
(4,100 |
) |
|
|
(2,870 |
) |
|
|
(12,300 |
) |
|
|
(2,870 |
) |
|||||||
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS |
|
|
(1,874 |
) |
|
|
(64,490 |
) |
|
|
(36,153 |
) |
|
|
(103,573 |
) |
|||||||
WEIGHTED AVERAGE COMMON SHARES OUTSTANDING— BASIC AND DILUTED |
|
|
26,220 |
|
|
|
21,554 |
|
|
|
25,798 |
|
|
|
13,669 |
|
|||||||
NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS— BASIC AND DILUTED |
|
$ |
(0.07 |
) |
|
$ |
(2.99 |
) |
|
$ |
(1.40 |
) |
|
$ |
(7.58 |
) |
|||||||
|
||||||||
|
|
|
|
|
|
|
||
|
|
2021 |
|
|
2020 |
|
||
ASSETS |
|
|
|
|
|
|
|
|
CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Cash and restricted cash |
|
$ |
16,006 |
|
|
$ |
34,881 |
|
Accounts receivable—net |
|
|
66,471 |
|
|
|
54,102 |
|
Contract assets |
|
|
46,270 |
|
|
|
38,576 |
|
Prepaid and other current assets |
|
|
9,839 |
|
|
|
6,709 |
|
Total current assets |
|
|
138,586 |
|
|
|
134,268 |
|
NON-CURRENT ASSETS: |
|
|
|
|
|
|
|
|
Property and equipment—net |
|
|
31,078 |
|
|
|
34,399 |
|
Operating lease right-of-use asset—net |
|
|
23,111 |
|
|
|
— |
|
Finance lease right-of-use asset—net |
|
|
7,493 |
|
|
|
— |
|
|
|
|
304,237 |
|
|
|
274,667 |
|
Other intangible assets—net |
|
|
160,239 |
|
|
|
154,854 |
|
Other assets |
|
|
2,874 |
|
|
|
4,538 |
|
TOTAL ASSETS |
|
$ |
667,618 |
|
|
$ |
602,726 |
|
LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Accounts payable and other accrued liabilities |
|
$ |
42,373 |
|
|
$ |
34,877 |
|
Accrued payroll and benefits |
|
|
22,485 |
|
|
|
21,181 |
|
Business acquisitions contingent consideration, current |
|
|
31,152 |
|
|
|
49,902 |
|
Current portion of operating lease liabilities |
|
|
6,715 |
|
|
|
— |
|
Current portion of finance lease liabilities |
|
|
3,174 |
|
|
|
— |
|
Current portion of long-term debt |
|
|
8,750 |
|
|
|
5,583 |
|
Total current liabilities |
|
|
114,649 |
|
|
|
111,543 |
|
NON-CURRENT LIABILITIES: |
|
|
|
|
|
|
|
|
Business acquisitions contingent consideration, long-term |
|
|
4,200 |
|
|
|
4,565 |
|
Other non-current liabilities |
|
|
2,446 |
|
|
|
2,523 |
|
Deferred tax liabilities—net |
|
|
3,059 |
|
|
|
2,815 |
|
Conversion option |
|
|
22,537 |
|
|
|
20,886 |
|
Operating lease liability—net of current portion |
|
|
16,584 |
|
|
|
— |
|
Finance lease liability—net of current portion |
|
|
4,641 |
|
|
|
— |
|
Long-term debt—net of deferred financing fees |
|
|
200,876 |
|
|
|
170,321 |
|
Total liabilities |
|
|
368,992 |
|
|
|
312,653 |
|
COMMITMENTS AND CONTINGENCIES |
|
|
|
|
|
|
|
|
CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK PAR VALUE— |
|
|
|
|
|
|
|
|
Authorized, issued and outstanding shares: 17,500 at
|
|
|
152,928 |
|
|
|
152,928 |
|
STOCKHOLDERS’ EQUITY: |
|
|
|
|
|
|
|
|
Common stock,
26,525,844 and 24,932,527 at respectively |
|
|
|
|
|
|
— |
|
Additional paid-in-capital |
|
|
291,850 |
|
|
|
259,427 |
|
Accumulated deficit |
|
|
(146,206 |
) |
|
|
(122,353 |
) |
Accumulated other comprehensive income |
|
|
54 |
|
|
|
71 |
|
Total stockholders’ equity |
|
|
145,698 |
|
|
|
137,145 |
|
TOTAL LIABILITIES, CONVERTIBLE AND REDEEMABLE SERIES A-2 PREFERRED STOCK AND STOCKHOLDERS’ EQUITY |
|
$ |
667,618 |
|
|
$ |
602,726 |
|
|
||||||||
|
|
Nine Months Ended |
|
|||||
|
|
2021 |
|
|
2020 |
|
||
OPERATING ACTIVITIES: |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(23,853 |
) |
|
$ |
(58,761 |
) |
Adjustments to reconcile net loss to net cash used in operating activities: |
|
|
|
|
|
|
|
|
Provision for bad debt |
|
|
803 |
|
|
|
6,445 |
|
Depreciation and amortization |
|
|
33,145 |
|
|
|
27,084 |
|
Amortization of right-of-use asset |
|
|
5,947 |
|
|
|
— |
|
Stock-based compensation expense |
|
|
6,587 |
|
|
|
3,439 |
|
Fair value changes in embedded derivatives |
|
|
1,651 |
|
|
|
17,492 |
|
Fair value changes in business acquisitions contingent consideration |
|
|
24,035 |
|
|
|
17,387 |
|
Deferred income taxes |
|
|
232 |
|
|
|
(1,563 |
) |
Other |
|
|
68 |
|
|
|
(1,180 |
) |
Debt extinguishment costs |
|
|
4,052 |
|
|
|
— |
|
Changes in operating assets and liabilities—net of acquisitions: |
|
|
|
|
|
|
|
|
Accounts receivable and contract assets |
|
|
(12,503 |
) |
|
|
(7,736 |
) |
Prepaid expenses and other current assets |
|
|
(1,781 |
) |
|
|
(1,349 |
) |
Accounts payable and other accrued liabilities |
|
|
(3,422 |
) |
|
|
(4,829 |
) |
Accrued payroll and benefits |
|
|
61 |
|
|
|
6,084 |
|
Payment of contingent consideration and other assumed purchase price obligations |
|
|
(15,549 |
) |
|
|
(6,390 |
) |
Change in operating leases |
|
|
(5,765 |
) |
|
|
— |
|
Net cash provided by (used in) operating activities |
|
|
13,708 |
|
|
|
(3,877 |
) |
INVESTING ACTIVITIES: |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(5,405 |
) |
|
|
(5,366 |
) |
Proprietary software development and other software costs |
|
|
(241 |
) |
|
|
(370 |
) |
Purchase price true ups |
|
|
(8,562 |
) |
|
|
— |
|
Proceeds from net working capital adjustment related to acquisitions |
|
|
— |
|
|
|
2,819 |
|
Cash paid for acquisitions—net of cash acquired |
|
|
(36,480 |
) |
|
|
(173,923 |
) |
Net cash used in investing activities |
|
|
(50,688 |
) |
|
|
(176,840 |
) |
FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Proceeds from line of credit |
|
|
109,000 |
|
|
|
104,390 |
|
Payments on line of credit |
|
|
(72,000 |
) |
|
|
(201,980 |
) |
Proceeds from term loans |
|
|
175,000 |
|
|
|
175,000 |
|
Repayment of term loan |
|
|
(173,905 |
) |
|
|
(49,297 |
) |
Payment of contingent consideration and other purchase price obligations |
|
|
(9,605 |
) |
|
|
(6,004 |
) |
Repayment of finance leases |
|
|
(1,884 |
) |
|
|
(2,257 |
) |
Proceeds from issuance of common stock in connection with initial public offering, net of issuance costs |
|
|
— |
|
|
|
161,288 |
|
Payments of deferred offering costs |
|
|
— |
|
|
|
(2,925 |
) |
Prepayment premium on credit facility |
|
|
— |
|
|
|
(351 |
) |
Debt issuance costs |
|
|
(2,590 |
) |
|
|
(4,866 |
) |
Proceeds from issuance of common stock for exercised stock options |
|
|
6,032 |
|
|
|
171 |
|
Issuance of convertible and redeemable Series A-2 preferred stock and warrant |
|
|
— |
|
|
|
173,664 |
|
Redemption of the Series A-1 preferred stock |
|
|
— |
|
|
|
(131,821 |
) |
Dividend payment to the Series A-2 shareholders |
|
|
(12,300 |
) |
|
|
(2,870 |
) |
Exercise of warrant options |
|
|
— |
|
|
|
25 |
|
Net cash provided by financing activities |
|
|
17,748 |
|
|
|
212,167 |
|
CHANGE IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH |
|
|
(19,232 |
) |
|
|
31,450 |
|
Foreign exchange impact on cash balance |
|
|
357 |
|
|
|
43 |
|
CASH, CASH EQUIVALENTS AND RESTRICTED CASH: |
|
|
|
|
|
|
|
|
Beginning of year |
|
|
34,881 |
|
|
|
6,884 |
|
End of period |
|
$ |
16,006 |
|
|
$ |
38,377 |
|
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION: |
|
|
|
|
|
|
|
|
Cash paid for interest |
|
$ |
4,649 |
|
|
$ |
9,368 |
|
Cash paid for income tax |
|
$ |
958 |
|
|
$ |
171 |
|
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING ACTIVITIES: |
|
|
|
|
|
|
|
|
Series A-1 preferred stock deemed dividends—net of return from holders |
|
$ |
— |
|
|
$ |
24,341 |
|
Series A-1 preferred stock dividend paid in common shares |
|
$ |
— |
|
|
$ |
26,801 |
|
Accrued purchases of property and equipment |
|
$ |
1,171 |
|
|
$ |
486 |
|
Property and equipment purchased under finance leases |
|
$ |
1,766 |
|
|
$ |
1,753 |
|
Accretion of the redeemable series A-1 preferred stock to redeemable value |
|
$ |
— |
|
|
$ |
17,601 |
|
Common stock issued to acquire new businesses |
|
$ |
6,020 |
|
|
$ |
25,000 |
|
Acquisitions unpaid contingent consideration |
|
$ |
35,352 |
|
|
$ |
58,912 |
|
Offering costs included in accounts payable and other accrued liabilities |
|
$ |
389 |
|
|
$ |
1,237 |
|
Acquisitions contingent consideration and purchase price true ups paid in shares |
|
$ |
26,084 |
|
|
$ |
— |
|
Non-GAAP Financial Information
In addition to our results under GAAP, in this release we also present certain other supplemental financial measures of financial performance that are not required by, or presented in accordance with, GAAP, including Adjusted EBITDA and Adjusted EBITDA margin. We calculate Adjusted EBITDA as net income (loss) before interest expense, income tax expense (benefit) and depreciation and amortization, adjusted for the impact of certain other items, including stock-based compensation expense and acquisition-related costs, as set forth in greater detail in the table below. Adjusted EBITDA margin represents Adjusted EBITDA as a percentage of revenues for a given period.
Adjusted EBITDA and Adjusted EBITDA margin are two of the primary metrics used by management to evaluate our financial performance and compare it to that of our peers, evaluate the effectiveness of our business strategies, make budgeting and capital allocation decisions and in connection with our executive incentive compensation. These measures are also frequently used by analysts, investors and other interested parties to evaluate companies in our industry. Further, we believe they are helpful in highlighting trends in our operating results because they allow for more consistent comparisons of financial performance between periods by excluding gains and losses that are non-operational in nature or outside the control of management, as well as items that may differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments.
These non-GAAP measures do, however, have certain limitations and should not be considered as an alternative to net income (loss) or any other performance measure derived in accordance with GAAP. Our presentation of Adjusted EBITDA and Adjusted EBITDA margin should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items for which we may make adjustments. In addition, Adjusted EBITDA and Adjusted EBITDA margin may not be comparable to similarly titled measures used by other companies in our industry or across different industries, and other companies may not present these or similar measures. Management compensates for these limitations by using these measures as supplemental financial metrics and in conjunction with our results prepared in accordance with GAAP. We encourage investors and others to review our financial information in its entirety, not to rely on any single measure and to view Adjusted EBITDA and Adjusted EBITDA margin in conjunction with the related GAAP measures.
Additionally, we have provided estimates regarding Adjusted EBITDA for 2021. These projections account for estimates of revenue, operating margins and corporate and other costs. However, we cannot reconcile our projection of Adjusted EBITDA to net income (loss), the most directly comparable GAAP measure, without unreasonable efforts because of the unpredictable or unknown nature of certain significant items excluded from Adjusted EBITDA and the resulting difficulty in quantifying the amounts thereof that are necessary to estimate net income (loss). Specifically, we are unable to estimate for the future impact of certain items, including income tax (expense) benefit, stock-based compensation expense, fair value changes and the accounting for the issuance of the Series A-2 preferred stock. We expect the variability of these items could have a significant impact on our reported GAAP financial results.
|
||||||||||||||||
|
|
For the Three Months
|
|
|
For the Nine Months
|
|
||||||||||
(in thousands) |
|
2021 |
|
|
2020 |
|
|
2021 |
|
|
2020 |
|
||||
Net income (loss) |
|
$ |
2,226 |
|
|
$ |
(30,737 |
) |
|
$ |
(23,853 |
) |
|
$ |
(58,761 |
) |
Interest expense |
|
|
1,722 |
|
|
|
3,043 |
|
|
|
11,208 |
|
|
|
10,896 |
|
Income tax expense (benefit) |
|
|
902 |
|
|
|
3,348 |
|
|
|
648 |
|
|
|
(1,563 |
) |
Depreciation and amortization |
|
|
11,471 |
|
|
|
9,740 |
|
|
|
33,145 |
|
|
|
27,084 |
|
EBITDA |
|
$ |
16,321 |
|
|
$ |
(14,606 |
) |
|
$ |
21,148 |
|
|
$ |
(22,344 |
) |
Stock-based compensation (1) |
|
|
2,365 |
|
|
|
1,149 |
|
|
|
6,587 |
|
|
|
3,439 |
|
Start-up losses and investment in new services (2) |
|
|
1,186 |
|
|
|
602 |
|
|
|
3,276 |
|
|
|
1,283 |
|
Acquisition costs (3) |
|
|
913 |
|
|
|
6 |
|
|
|
1,656 |
|
|
|
3,767 |
|
Fair value changes in financial instruments (4) |
|
|
531 |
|
|
|
9,710 |
|
|
|
1,651 |
|
|
|
17,492 |
|
Expenses related to financing transactions (5) |
|
|
— |
|
|
|
— |
|
|
|
50 |
|
|
|
277 |
|
Fair value changes in business acquisitions contingent consideration (6) |
|
|
— |
|
|
|
13,404 |
|
|
|
24,035 |
|
|
|
17,387 |
|
Short term purchase accounting fair value adjustment to deferred revenue (7) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
243 |
|
IPO expense (8) |
|
|
— |
|
|
|
6,378 |
|
|
|
— |
|
|
|
6,908 |
|
Discontinued service lines and closing of Berkley lab (9) |
|
|
— |
|
|
|
30 |
|
|
|
— |
|
|
|
7,526 |
|
Other losses and expenses(10) |
|
|
171 |
|
|
|
33 |
|
|
|
846 |
|
|
|
179 |
|
Adjusted EBITDA |
|
$ |
21,487 |
|
|
$ |
16,706 |
|
|
$ |
59,249 |
|
|
$ |
36,157 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents non-cash stock-based compensation expenses related to option awards issued to employees and restricted stock grants issued to directors. |
|
(2) |
Represent start-up losses related to losses incurred on (i) the expansion of lab testing methods and lab capacity, including into new geographies, (ii) expansion of our Remediation and Consulting services and (iii) expansion into |
|
(3) |
Includes financial and tax diligence, consulting, legal, valuation, accounting and travel costs and acquisition-related incentives related to our acquisition activity. |
|
(4) |
Amounts relate to the change in fair value of the embedded derivatives and warrant option attached to the Series A-1 preferred stock and the Series A-2 preferred stock. |
|
(5) |
Amounts represent non-capitalizable expenses associated with refinancing and amending our debt facilities. |
|
(6) |
Reflects the difference between the expected settlement value of acquisition related earn-out payments at the time of the closing of acquisitions and the expected (or actual) value of earn-outs at the end of the relevant period. |
|
(7) |
Purchase accounting fair value adjustment to deferred revenue represents the impact of the fair value adjustment to the carrying value of deferred revenue as of the date of acquisition of ECT2. |
|
(8) |
Represents expenses incurred by us to prepare for our initial public offering, as well as costs from IPO-related bonuses. |
|
(9) |
Represents losses from the Discontinued Service Lines and the Berkeley lab. |
|
(10) |
Represents non-operational charges incurred as a result of lease abandonments and non-capitalizable costs related to the implementation of a new ERP and net of insurance gains. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109006558/en/
Investor Relations:
(949) 988-3383
ir@montrose-env.com
Media Relations:
(646) 361-1427
Montrose@icrinc.com
Source:
FAQ
What were Montrose Environmental Group's Q3 2021 financial results?
How did Montrose's Adjusted EBITDA perform in Q3 2021?
What changes did Montrose make to its full-year 2021 guidance?
What is Montrose's current leverage ratio?